In contrast, the level of FcRn was statistically higher in subpopulations of non-classical monocytes (CD14 + CD16+ monocytes) from SLE patients compared to healthy donors, providing an initial perspective to further explore its role in the pathophysiology of SLE [161]. Here, FCGR3A is linked to systemic lupus erythematosus.